Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-17

Clinical Trial Update: Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating Cinobufacini tablets in combination with standard chemotherapy for diffuse large B-cell lymphoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cinobufacini tablets (Cinobufacini)

Snippet

Sponsor: Xinjiang Medical University | Conditions: Diffuse, Large B-Cell, Lymphoma | Phase 2, Phase 3 | Status: UNKNOWN